rs200334999
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001101426.4(CRPPA):c.808C>T(p.Leu270Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000912 in 1,612,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.808C>T | p.Leu270Phe | missense_variant | Exon 5 of 10 | ENST00000407010.7 | NP_001094896.1 | |
CRPPA | NM_001368197.1 | c.703C>T | p.Leu235Phe | missense_variant | Exon 4 of 9 | NP_001355126.1 | ||
CRPPA | NM_001101417.4 | c.658C>T | p.Leu220Phe | missense_variant | Exon 4 of 9 | NP_001094887.1 | ||
CRPPA | NR_160656.1 | n.901-23222C>T | intron_variant | Intron 3 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000133 AC: 33AN: 248010Hom.: 0 AF XY: 0.0000744 AC XY: 10AN XY: 134480
GnomAD4 exome AF: 0.0000548 AC: 80AN: 1460412Hom.: 0 Cov.: 29 AF XY: 0.0000509 AC XY: 37AN XY: 726428
GnomAD4 genome AF: 0.000440 AC: 67AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74434
ClinVar
Submissions by phenotype
not provided Uncertain:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26687144) -
- -
- -
not specified Uncertain:1
- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 270 of the ISPD protein (p.Leu270Phe). This variant is present in population databases (rs200334999, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with ISPD-related conditions. ClinVar contains an entry for this variant (Variation ID: 289678). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ISPD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Congenital Muscular Dystrophy, alpha-dystroglycan related Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at